Post-earnings recap
Reported
Mon, Aug 15, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Roivant Sciences reported a larger-than-expected loss per share, which contributed to a decline in the stock price by 2.75%. Investors may be concerned about the lack of revenue information and forward guidance, leading to uncertainty about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.48 | N/A | -60.00% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—